Skip to main content

Table 1 Pathology

From: Increased lesion detectability in patients with locally advanced breast cancer—A pilot study using dynamic whole-body [18F]FDG PET/CT

Ductal/lobular (n)

8/2

ER+/HER2 2+ (n)

5

ER-/HER2 2+ (n)

0

ER+/HER2-

4

ER-/HER2- (triple neg.)

1

Grade 1/2/3 (n)

1/5/4

  1. Pathology results for the ten included patients